 | • レポートコード：MRC2102QY15451 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、135ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の腫瘍壊死因子受容体スーパーファミリーメンバー1A市場について種類別（LY-3232094、EYS-606、SRT-100、その他）、用途別（生殖器疣贅、黒色腫、多発性硬化症、乾癬、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・腫瘍壊死因子受容体スーパーファミリーメンバー1A市場の概要 ・世界の主要地域別腫瘍壊死因子受容体スーパーファミリーメンバー1A市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー1A市場規模2015-2026：種類別（LY-3232094、EYS-606、SRT-100、その他） ・世界の腫瘍壊死因子受容体スーパーファミリーメンバー1A市場規模2015-2026：用途別（生殖器疣贅、黒色腫、多発性硬化症、乾癬、その他） ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの米国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aのヨーロッパ市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの中国市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの日本市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの東南アジア市場規模2015-2020 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの製造コスト分析 ・販売チャネル、流通業者、顧客 ・腫瘍壊死因子受容体スーパーファミリーメンバー1Aの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market
The global Tumor Necrosis Factor Receptor Superfamily Member 1A market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Tumor Necrosis Factor Receptor Superfamily Member 1A Scope and Market Size
The global Tumor Necrosis Factor Receptor Superfamily Member 1A market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Tumor Necrosis Factor Receptor Superfamily Member 1A market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Tumor Necrosis Factor Receptor Superfamily Member 1A market is segmented into
LY-3232094
EYS-606
SRT-100
Others
Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 1A market is segmented into
Genital Warts
Melanoma
Multiple Sclerosis
Psoriasis
Others
The Tumor Necrosis Factor Receptor Superfamily Member 1A market is analysed and market size information is provided by regions (countries). Segment by Application, the Tumor Necrosis Factor Receptor Superfamily Member 1A market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share Analysis
Tumor Necrosis Factor Receptor Superfamily Member 1A market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Tumor Necrosis Factor Receptor Superfamily Member 1A business, the date to enter into the Tumor Necrosis Factor Receptor Superfamily Member 1A market, Tumor Necrosis Factor Receptor Superfamily Member 1A product introduction, recent developments, etc.
The major vendors covered:
Addex Therapeutics Ltd
G&E Herbal Biotechnology Co., Ltd.
GlaxoSmithKline Plc
Inflamalps SA
Polaris Pharmaceuticals, Inc.
1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Overview
1.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Product Scope
1.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Segment by Type
1.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales by Type (2020-2026)
1.2.2 LY-3232094
1.2.3 EYS-606
1.2.4 SRT-100
1.2.5 Others
1.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Segment by Application
1.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Comparison by Application (2020-2026)
1.3.2 Genital Warts
1.3.3 Melanoma
1.3.4 Multiple Sclerosis
1.3.5 Psoriasis
1.3.6 Others
1.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Estimates and Forecasts (2015-2026)
1.4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Growth Rate (2015-2026)
1.4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue and Growth Rate (2015-2026)
1.4.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price Trends (2015-2026)
2 Tumor Necrosis Factor Receptor Superfamily Member 1A Estimate and Forecast by Region
2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Region (2015-2020)
2.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region (2015-2020)
2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
2.4.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
2.4.3 China Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
2.4.4 Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
2.4.6 India Tumor Necrosis Factor Receptor Superfamily Member 1A Estimates and Projections (2015-2026)
3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Competition Landscape by Players
3.1 Global Top Tumor Necrosis Factor Receptor Superfamily Member 1A Players by Sales (2015-2020)
3.2 Global Top Tumor Necrosis Factor Receptor Superfamily Member 1A Players by Revenue (2015-2020)
3.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2019)
3.4 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Average Price by Company (2015-2020)
3.5 Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Tumor Necrosis Factor Receptor Superfamily Member 1A Players (Opinion Leaders)
4 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Type
4.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Review by Type (2015-2020)
4.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
4.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Type (2015-2020)
4.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Type (2015-2020)
4.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Forecast by Type (2021-2026)
4.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Forecast by Type (2021-2026)
4.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price Forecast by Type (2021-2026)
5 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size by Application
5.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Historic Market Review by Application (2015-2020)
5.1.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
5.1.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Application (2015-2020)
5.1.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price by Application (2015-2020)
5.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Forecast by Application (2021-2026)
5.2.2 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Forecast by Application (2021-2026)
5.2.3 Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price Forecast by Application (2021-2026)
6 United States Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
6.1 United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
6.2 United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
6.3 United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
7 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
7.1 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
7.2 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
7.3 Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
8 China Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
8.1 China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
8.2 China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
8.3 China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
9 Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
9.1 Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (3015-3030)
9.2 Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
9.3 Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
10 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
10.1 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
11 India Tumor Necrosis Factor Receptor Superfamily Member 1A Market Facts & Figures
11.1 India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
11.2 India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
11.3 India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Tumor Necrosis Factor Receptor Superfamily Member 1A Business
12.1 Addex Therapeutics Ltd
12.1.1 Addex Therapeutics Ltd Corporation Information
12.1.2 Addex Therapeutics Ltd Business Overview
12.1.3 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
12.1.5 Addex Therapeutics Ltd Recent Development
12.2 G&E Herbal Biotechnology Co., Ltd.
12.2.1 G&E Herbal Biotechnology Co., Ltd. Corporation Information
12.2.2 G&E Herbal Biotechnology Co., Ltd. Business Overview
12.2.3 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2015-2020)
12.2.4 G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
12.2.5 G&E Herbal Biotechnology Co., Ltd. Recent Development
12.3 GlaxoSmithKline Plc
12.3.1 GlaxoSmithKline Plc Corporation Information
12.3.2 GlaxoSmithKline Plc Business Overview
12.3.3 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2015-2020)
12.3.4 GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
12.3.5 GlaxoSmithKline Plc Recent Development
12.4 Inflamalps SA
12.4.1 Inflamalps SA Corporation Information
12.4.2 Inflamalps SA Business Overview
12.4.3 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
12.4.5 Inflamalps SA Recent Development
12.5 Polaris Pharmaceuticals, Inc.
12.5.1 Polaris Pharmaceuticals, Inc. Corporation Information
12.5.2 Polaris Pharmaceuticals, Inc. Business Overview
12.5.3 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Products Offered
12.5.5 Polaris Pharmaceuticals, Inc. Recent Development
…
13 Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturing Cost Analysis
13.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 1A
13.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors List
14.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Customers
15 Market Dynamics
15.1 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Trends
15.2 Tumor Necrosis Factor Receptor Superfamily Member 1A Opportunities and Drivers
15.3 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
15.4 Tumor Necrosis Factor Receptor Superfamily Member 1A Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Tumor Necrosis Factor Receptor Superfamily Member 1A Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Region (2015-2020)
Table 5. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Region (2015-2020)
Table 6. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Region (2015-2020)
Table 8. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share Forecast by Region (2021-2026)
Table 12. Global Tumor Necrosis Factor Receptor Superfamily Member 1A (K Units) of Key Companies (2015-2020)
Table 13. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Company (2015-2020)
Table 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Company (2015-2020)
Table 16. Global Tumor Necrosis Factor Receptor Superfamily Member 1A by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A as of 2019)
Table 17. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Manufacturing Sites and Area Served
Table 19. Manufacturers Tumor Necrosis Factor Receptor Superfamily Member 1A Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Tumor Necrosis Factor Receptor Superfamily Member 1A Players
Table 22. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 23. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Type (2015-2020)
Table 24. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (K Units) by Type (2015-2020)
Table 26. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Type (2021-2026)
Table 27. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Type (2021-2026)
Table 29. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (K Units) by Type (2021-2026)
Table 30. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 31. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Application (2015-2020)
Table 32. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (K Units) by Application (2015-2020)
Table 34. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2021-2026)
Table 35. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Share by Application (2021-2026)
Table 36. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Application (2021-2026)
Table 38. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price (K Units) by Application (2021-2026)
Table 39. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 40. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 41. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 42. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 43. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 44. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
Table 45. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 46. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 47. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 48. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 49. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 50. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 51. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 52. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 53. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 54. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 55. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 56. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
Table 57. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 58. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 59. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 60. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 61. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 62. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
Table 69. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Company (2015-2020)
Table 70. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company (2015-2020)
Table 71. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Type (2015-2020)
Table 72. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type (2015-2020)
Table 73. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) by Application (2015-2020)
Table 74. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application (2015-2020)
Table 75. Addex Therapeutics Ltd Corporation Information
Table 76. Addex Therapeutics Ltd Description and Business Overview
Table 77. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Addex Therapeutics Ltd Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 79. Addex Therapeutics Ltd Recent Development
Table 80. G&E Herbal Biotechnology Co., Ltd. Corporation Information
Table 81. G&E Herbal Biotechnology Co., Ltd. Description and Business Overview
Table 82. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. G&E Herbal Biotechnology Co., Ltd. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 84. G&E Herbal Biotechnology Co., Ltd. Recent Development
Table 85. GlaxoSmithKline Plc Corporation Information
Table 86. GlaxoSmithKline Plc Description and Business Overview
Table 87. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. GlaxoSmithKline Plc Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 89. GlaxoSmithKline Plc Recent Development
Table 90. Inflamalps SA Corporation Information
Table 91. Inflamalps SA Description and Business Overview
Table 92. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Inflamalps SA Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 94. Inflamalps SA Recent Development
Table 95. Polaris Pharmaceuticals, Inc. Corporation Information
Table 96. Polaris Pharmaceuticals, Inc. Description and Business Overview
Table 97. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Polaris Pharmaceuticals, Inc. Tumor Necrosis Factor Receptor Superfamily Member 1A Product
Table 99. Polaris Pharmaceuticals, Inc. Recent Development
Table 100. Production Base and Market Concentration Rate of Raw Material
Table 101. Key Suppliers of Raw Materials
Table 102. Tumor Necrosis Factor Receptor Superfamily Member 1A Distributors List
Table 103. Tumor Necrosis Factor Receptor Superfamily Member 1A Customers List
Table 104. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Key Trends
Table 105. Tumor Necrosis Factor Receptor Superfamily Member 1A Key Opportunities and Drivers
Table 106. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Challenges
Table 107. Research Programs/Design for This Report
Table 108. Key Data Information from Secondary Sources
Table 109. Key Data Information from Primary Sources
List of Figures
Figure 1. Tumor Necrosis Factor Receptor Superfamily Member 1A Product Picture
Figure 2. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Application in 2020 & 2026
Figure 6. Genital Warts Examples
Figure 7. Melanoma Examples
Figure 8. Multiple Sclerosis Examples
Figure 9. Psoriasis Examples
Figure 10. Others Examples
Figure 11. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) Growth Rate (2015-2026)
Figure 12. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (US$ Million) Growth Rate (2015-2026)
Figure 13. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 14. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region: 2015 VS 2020
Figure 15. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Market Share by Region: 2021 VS 2026
Figure 16. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (K Units) Growth Rate (2015-2026)
Figure 18. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Million USD) Growth Rate (2015-2026)
Figure 20. China Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Million USD) and Growth Rate (2015-2026)
Figure 22. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Million USD) Growth Rate (2015-2026)
Figure 26. India Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue (Million USD) Growth Rate (2015-2026)
Figure 27. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales (Million USD) Growth Rate (2015-2026)
Figure 28. Global 5 Largest Tumor Necrosis Factor Receptor Superfamily Member 1A Players Market Share by Revenue in Tumor Necrosis Factor Receptor Superfamily Member 1A 2015 & 2019
Figure 29. Tumor Necrosis Factor Receptor Superfamily Member 1A Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 30. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Type (2015-2020)
Figure 31. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate by Type in 2015 & 2019
Figure 32. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Share by Application (2015-2020)
Figure 33. Global Tumor Necrosis Factor Receptor Superfamily Member 1A Revenue Growth Rate by Application in 2015 & 2019
Figure 34. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 35. United States Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 36. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company in 2019
Figure 37. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 38. Europe Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2019
Figure 39. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company in 2019
Figure 40. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 41. China Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2019
Figure 42. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company in 2019
Figure 43. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 44. Japan Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2019
Figure 45. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company in 2019
Figure 46. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 47. Southeast Asia Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2019
Figure 48. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Company in 2019
Figure 49. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Type in 2019
Figure 50. India Tumor Necrosis Factor Receptor Superfamily Member 1A Sales Market Share by Application in 2019
Figure 51. Key Raw Materials Price Trend
Figure 52. Manufacturing Cost Structure of Tumor Necrosis Factor Receptor Superfamily Member 1A
Figure 53. Manufacturing Process Analysis of Tumor Necrosis Factor Receptor Superfamily Member 1A
Figure 54. Tumor Necrosis Factor Receptor Superfamily Member 1A Industrial Chain Analysis
Figure 55. Channels of Distribution
Figure 56. Distributors Profiles
Figure 57. Porter's Five Forces Analysis
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed
腫瘍壊死因子受容体スーパーファミリーメンバー18の世界市場レポート2020 Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 18 Market The global Tumor Necrosis Factor Receptor Superfamily Member 18 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tumor Necr…- 腫瘍壊死因子受容体スーパーファミリーメンバー4の世界市場レポート2020 Market Analysis and Insights: Global Tumor Necrosis Factor Receptor Superfamily Member 4 Market The global Tumor Necrosis Factor Receptor Superfamily Member 4 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Tumor Necros…
- ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
- 凝固因子濃縮物の世界市場レポート2020 Market Analysis and Insights: Global Coagulation Factor Concentrate Market The global Coagulation Factor Concentrate market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Coagulation Factor Concentrate Scope and Market Size T…
- スフィンゴシン1-リン酸受容体1の世界市場レポート2020 Sphingosine-1-phosphate receptor 1 (S1P receptor 1 or S1P1), also known as endothelial differentiation gene 1 (EDG1) is a protein that in humans is encoded by the S1PR1 gene. S1PR1 is a G-protein-coupled receptor which binds the bioactive signaling molecule sphingosine 1-phosphate (S1P). S1PR1 belon…